The pharmacy is now in our new location at 22629 Twain Harte Drive, Suite D, Twain Harte, CA 95383!
Download our NEW mobile app!
Please be advised the pharmacy hours have changed on Fridays & Saturdays:
Friday - 9am to 6pm (Closed 1pm to 2pm for Lunch)
Saturday - Closed
Recursos del Paciente
Manténgase sano!
Resultados de su búsqueda "Cancer: Kidney".
01 Aug
Cancer Rates Rising in Gen Xers and Millennials. The Question Is Why?
Researchers analyzed cancer incidence and mortality rates across generations and found a significant increase in many types of cancer among Generation X and millennials.
Resultados de noticias de salud - 8
Combo Treatment Doubles Survival for Patients With Advanced Kidney Cancer
- Ernie Mundell HealthDay Reporter
- September 17, 2024
- Página completa
A small clinical trial suggests that a duo of drugs can extend survival for people battling advanced kidney cancer.
Researchers at Roswell Park Comprehensive Cancer Center in Buffalo, N.Y., developed the new regimen, a combination of pazopanib (
Injected Opdivo for Kidney Cancer Works Equally Well as IV Form: Study
- Ernie Mundell HealthDay Reporter
- January 30, 2024
- Página completa
Opdivo, one of the new generation of immunotherapy cancer treatments, appears to help kidney cancer patients equally well when given as a quick injection versus the current method of intravenous delivery, a new study finds.
The results of the new trial using injected Opd...
Weight-Loss Surgery May Greatly Lower Odds for Many Cancers
- Dennis Thompson HealthDay Reporter
- June 8, 2022
- Página completa
Dropping a load of pounds through weight-loss surgery can significantly decrease your risk of developing or dying from cancer, according to three new studies.
Obese folks who underwent bariatric surgery were at least two times less likely to develop certain types of canc...
New Combo Immunotherapy Prolongs Survival in Patients With Advanced Kidney Cancer
- Denise Mann HealthDay Reporter
- April 22, 2022
- Página completa
The use of immunotherapy and/or targeted drugs revolutionized the treatment of many cancers, but some people grow resistant to immunotherapy drugs and relapse as a result.
Missed Cancer Screenings During Pandemic Could Raise Death Rate for Years
- March 21, 2022
- Página completa
The early months of the COVID-19 pandemic kept millions of Americans away from routine cancer screenings. Now a new study finds that many U.S. screening programs were still not back to normal by 2021.
The study, of more than 700 cancer facilities nationwide, found that i...
Cancer Patients May Be at Higher Odds for Rare Neurological Disorder
- March 3, 2022
- Página completa
People with cancer may be at increased risk for a rare neurological disorder called Guillain-Barré syndrome, new research has found.
"Previous studies have suggested there may be a link between cancer and Guillain-Barré syndrome, but just how often people develop <...
Women at Higher Odds for Side Effects From Some Cancer Treatments
- February 15, 2022
- Página completa
Gender differences extend to cancer treatments, with women having a higher risk of severe side effects from certain treatments than men, a new study finds.
Previous research concluded women tend to have more side effects from chemotherapy, and this new paper shows the sa...
Cancer Care Costs U.S. $156 Billion Per Year; Drugs a Major Factor
- Robert Preidt
- October 13, 2021
- Página completa
Private insurers paid out about $156.2 billion in 2018 for U.S. patients with the 15 most common cancers.
Medication was the largest expense and drugs for breast, lung, lymphoma and colon cancers accounted for the largest chunk of those costs, according to a Penn State C...